NovaBridge Biosciences (NBP)

SEC filing

NovaBridge Biosciences

NBP · CIK 1778016

4 · Sep 1, 2026 · EVP, Clinical Development Xu Cong Claire sold 3,282 shares at $0.79/share ($2,593); exercised options for 13.46K shares

EVP, Clinical Development Xu Cong Claire sold 3,282 shares at $0.79/share ($2,593); exercised options for 13.46K shares

xslF345X06/form4-09012026_060901.xml

xslF345X06/form4-09012026_060901.xmlSEC.gov

Graphics and non-inline formats (not embedded below).